Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Neurofibromatosis Type 1 in Children: A Single-Center Experience
Ayşe Gonca Kaçar1, Burcu Kılınc Oktay2, Simge Çınar Özel1
1Department of Pediatric Hematology and Oncology, İstanbul University-Cerrahpaşa School of Medicine, İstanbul, Turkey.
This study analyzed clinical features in children with Neurofibromatosis type 1 (NF-1), finding common symptoms like café au lait spots and highlighting the need for careful monitoring. Early diagnosis of NF-1 is crucial to prevent disease complications.
Area of Science:
- Pediatric Neurology
- Genetics
- Dermatology
Background:
- Neurofibromatosis type 1 (NF-1) is a common genetic disorder.
- It is an autosomal dominant neurocutaneous syndrome.
- Key features include café au lait spots, freckling, neurofibromas, and optic pathway gliomas.
Purpose of the Study:
- To analyze the clinical manifestations of NF-1 in a pediatric cohort.
- To identify common symptoms and complications in children diagnosed with NF-1.
Main Methods:
- Retrospective evaluation of pediatric patients diagnosed with NF-1 between 2000 and 2020.
- Analysis of demographic and clinical data.
Main Results:
- The study included 52 children (25 boys, 27 girls) with a median age of 5.9 years at diagnosis.
- Café au lait spots (96%) and freckling (46%) were most common.
- Other findings included neurofibromas (42%), optic gliomas (19%), cranial hamartomas (75%), orthopedic complications (25%), and neurocognitive disorders (21%).
Conclusions:
- Early diagnosis of NF-1 is vital for preventing disease progression and complications.
- Long-term monitoring for neurological development and secondary malignancies is essential for affected children.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023